We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

CIMB:MYXCIMB Group Holdings Bhd Analysis

Data as of 2026-06-10 - not real-time

MYR 7.41

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

CIMB shares are trading at MYR 7.41, which sits below the 20‑day (7.61), 50‑day (7.64) and 200‑day (7.77) simple moving averages, indicating a bearish price trend. The RSI of 39 suggests the stock is approaching oversold territory, while the MACD histogram is negative and the signal line is labeled “bearish”. Price is hugging the calculated support at MYR 7.20 and faces resistance near MYR 7.98; volatility over the past 30 days is elevated at roughly 19.5%, yet the beta is effectively neutral, implying limited systematic risk. Market sentiment is at the “Extreme Greed” end of the Fear & Greed Index (85.55), which may be inflating short‑term buying pressure.
Fundamentally, CIMB appears undervalued with a trailing PE of 10.3 versus an industry average of 16.6, and a forward PE of 9.2 supporting upside potential of about 22% relative to the consensus target of ~MYR 9.04. The dividend yield stands at an attractive 5.44% with a payout ratio of 55%, and the balance sheet shows ample cash (MYR 127 bn) against debt (MYR 108 bn). Operating margins are robust at 49% and profit margin at 37%, though revenue has slipped 2.6% year‑over‑year. Forward EPS of 0.80 suggests earnings improvement ahead.
Recent corporate actions include the appointment of Mak Joon Nien as CEO of Growth Markets and CIMB Singapore, signaling a strategic push into regional expansion, and the sale of the Thai automotive financing portfolio at a modest premium, which should streamline asset quality and focus on core banking activities.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bearish technical indicators (price below SMAs, negative MACD)
  • Proximity to support level at MYR 7.20
  • High dividend yield providing downside cushion

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Undervalued valuation metrics (PE 10.3 vs industry 16.6)
  • Strong dividend sustainability and attractive yield
  • Potential earnings upside reflected in forward EPS and target price

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Solid balance sheet with ample cash relative to debt
  • Strategic leadership change focusing on growth markets
  • Consistent dividend policy and value‑oriented fundamentals

Key Metrics & Analysis

Financial Health

Revenue Growth-2.60%
Profit Margin36.85%
P/E Ratio10.3
ROE11.31%
ROA1.03%
P/B Ratio1.2
Op. Cash FlowMYR-25971578880
Industry P/E16.6

Technical Analysis

TrendBearish
RSI39.2
SupportMYR 7.20
ResistanceMYR 7.98
MA 20MYR 7.61
MA 50MYR 7.64
MA 200MYR 7.77
MACDBearish
VolumeIncreasing
Fear & Greed Index85.55

Valuation

Target PriceMYR 9.03
Upside/Downside21.86%
GradeUndervalued
TypeValue
Dividend Yield5.44%

Risk Assessment

Beta-0.00
Volatility19.50%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.